Roche Holding AG (OTCMKTS:RHHBY) Shares Sold by Fulton Bank N.A.

Fulton Bank N.A. lessened its holdings in Roche Holding AG (OTCMKTS:RHHBY) by 12.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 12,956 shares of the company’s stock after selling 1,784 shares during the quarter. Fulton Bank N.A.’s holdings in Roche were worth $520,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the business. Cardinal Capital Management Inc. acquired a new position in shares of Roche in the 2nd quarter valued at $16,860,000. Saratoga Research & Investment Management increased its holdings in shares of Roche by 6.9% in the first quarter. Saratoga Research & Investment Management now owns 2,458,918 shares of the company’s stock valued at $78,489,000 after purchasing an additional 158,482 shares during the period. Meritage Portfolio Management raised its stake in shares of Roche by 186.9% in the first quarter. Meritage Portfolio Management now owns 174,714 shares of the company’s stock worth $5,577,000 after purchasing an additional 113,823 shares during the last quarter. Bard Financial Services Inc. lifted its holdings in shares of Roche by 112.1% during the third quarter. Bard Financial Services Inc. now owns 66,500 shares of the company’s stock worth $2,657,000 after purchasing an additional 35,150 shares during the period. Finally, Hantz Financial Services Inc. purchased a new stake in Roche in the second quarter valued at approximately $1,164,000.

Roche Stock Up 0.7 %

Shares of OTCMKTS RHHBY opened at $38.27 on Wednesday. The firm’s 50 day simple moving average is $40.16 and its 200-day simple moving average is $35.54. Roche Holding AG has a 12 month low of $29.20 and a 12 month high of $42.43.

Wall Street Analysts Forecast Growth

Several analysts have commented on RHHBY shares. Bank of America upgraded shares of Roche from a “neutral” rating to a “buy” rating in a research note on Friday, September 13th. Deutsche Bank Aktiengesellschaft downgraded shares of Roche from a “hold” rating to a “sell” rating in a research report on Friday, September 13th. Three analysts have rated the stock with a sell rating, one has issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold”.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.